REMOV-HDxNCT07348536
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion date changed from estimate of Apr 2026 to Nov 1, 2026 Show 4 more changesShow less
- Eligibility criteria expanded, about 6 words
- Completed without a posted recruiting period
- Start date changed from estimate of Apr 2026 to Apr 1, 2026
- Secondary endpoints: details revised at 1 of 3 entries
Notable Start date: Aug 10, 2025 to Apr 2026v2 Show 4 more changesShow less
- Trial status: Recruiting to Not Yet Recruiting
- Primary completion date: Oct 15, 2025 to Apr 2026
- Study completion date: Jan 20, 2026 to Dec 2029
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Global Removal Score of Uremic Toxins
Timeframe: During each dialysis intervention session (pre- and post-dialysis measurements), over a 4-week study period
Secondary (3)
Removal Rate of Individual Medium-Sized Uremic Toxins
Removal Rate of Small Solutes
Beta-2 Microglobulin Clearance by Kt/V
Arms and interventions
Expanded Hemodialysis Prescriptions and High-Volume Online HemodiafiltrationExperimental
Participants will receive three expanded hemodialysis sessions with different treatment durations (180, 210, and 240 minutes) in randomized order, followed by one session of high-volume online hemodiafiltration. Blood samples will be collected before and after each session to assess uremic toxin removal.
Devices: Expanded Hemodialysis With Medium Cut-Off Membrane, High-Volume Online Hemodiafiltration
Sites
1 site in 1 country
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiranMexico City, Mexico City, Mexico